Subscribe

Avantium N.V. (AVTX.AS)

EUR7.30 +0.13 (+1.81%)
NL AMS Basic Materials Chemicals - Specialty
Address Zekeringstraat 29-31 1014 BV
Amsterdam, NL
CEO Tom van Aken
Website avantium.com
IPO 2017-03-15
ISIN NL0015002IE0

Explore sections of this company profile

Also trades on Euronext Amsterdam · AVTX.AS (EUR) London Stock Exchange · 0RNP.L (EUR) Other OTC · AVTXF (USD)
Description

Avantium N.V., an Amsterdam-based chemical technology enterprise, specializes in the development and commercialization of sustainable chemistry innovations. Its operations are structured across three distinct segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. A core focus is on furandicarboxylic acid (FDCA), which serves as a crucial precursor for polyethylene furanoate (PEF) – a bio-based, recyclable plastic ideal for packaging applications. The company also supplies advanced catalyst testing systems, including its proprietary Flowrence system, designed for evaluating catalysts and adsorbents, alongside offering R&D support and refinery catalyst assessment services. Avantium is pioneering technologies such as "ray technology" for producing mono-ethylene glycol from industrial sugars and "dawn technology" for transforming non-food plant feedstocks into industrial sugars and lignin. These initiatives, along with its use of plantMEG for polyester manufacturing, underscore its commitment to renewable resources. Founded in 2000, Avantium N.V. continues to drive progress in green chemistry.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR7.30 +0.13 (+1.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
249.7K
Beta
1.15
Float Shares
7.59M
Free Float %
86.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.35% -6.67% +16.82% +28.40% +19.23% +26.90% -51.26% -74.58% -82.85% -92.39% -92.39%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
7.30
Ratings Trend (MoM) 80% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 4 -1
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-1.79
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    -30.6% Q4'25: -36.4% (vs Q4'23)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -372.2% Q4'25: -129.6% (vs Q4'23)
  • ✗
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -266.8% Q4'25: -397.1% (vs Q4'23)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    -298.8% Q4'25: -284.9% (vs Q4'23)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    -17.0% Q4'25: -35.0% (vs Q4'23)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    -82.4% ★ Q4'25: -54.7% (vs Q4'23)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    -4.18× Q4'25: -2.35× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.12) × ERP
WACC = 41% × Ke + 59% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 7.30
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
3 Rev. Ana.
4 EPS Ana. 		Dec 2027
5 Rev. Ana.
3 EPS Ana. 		Dec 2028
4 Rev. Ana.
2 EPS Ana. 		Dec 2029
3 Rev. Ana.
1 EPS Ana.
Revenue
12.65M
est: 11.86M (+6.6%)
11.28M
est: 13.22M (-14.6%)
13.82M
est: 12.66M (+9.2%)
9.86M
est: 15.68M (-37.1%)
10.92M
est: 13.78M (-20.8%)
17.83M
est: 20.20M (-11.8%)
19.70M
est: 21.40M (-7.9%)
21.04M
est: 27.64M (-23.9%)
14.59M
est: 17.63M (-17.2%)
35.89M
28.51M – 40.59M
+103.6% YoY
71.12M
59.21M – 81.42M
+98.2% YoY
91.49M
91.37M – 91.61M
+28.6% YoY
110.00M
90.06M – 125.37M
+20.2% YoY
EBITDA
-9.13M
est: -11.86M (+23.0%)
-22.63M
est: -12.84M (-76.2%)
-17.00M
est: -113.37M (+85.0%)
-14.91M
est: -23.52M (+36.6%)
-16.09M
est: -25.20M (+36.2%)
-19.59M
est: -28.36M (+30.9%)
-25.78M
est: -21.40M (-20.5%)
-24.52M
est: -34.48M (+28.9%)
-39.47M
est: -17.63M (-123.9%)
-35.89M
-40.59M – -28.51M
-103.6% YoY
-71.12M
-81.42M – -59.21M
-98.2% YoY
-91.49M
-91.61M – -91.37M
-28.6% YoY
-110.00M
-125.37M – -90.06M
-20.2% YoY
EBIT
-10.02M
est: -11.86M (+15.6%)
-24.43M
est: -10.11M (-141.6%)
-22.95M
est: -11.56M (-98.5%)
-22.47M
est: -29.86M (+24.7%)
-23.92M
est: -31.98M (+25.2%)
-27.73M
est: -35.99M (+22.9%)
-33.18M
est: -21.40M (-55.0%)
-29.72M
est: -43.76M (+32.1%)
-43.61M
est: -17.63M (-147.4%)
-35.89M
-40.59M – -28.51M
-103.6% YoY
-71.12M
-81.42M – -59.21M
-98.2% YoY
-91.49M
-91.61M – -91.37M
-28.6% YoY
-110.00M
-125.37M – -90.06M
-20.2% YoY
Net Income
-16.76M
est: -140.90M (+88.1%)
-68.38M
est: -169.95M (+59.8%)
-23.54M
est: -70.13M (+66.4%)
-22.83M
est: -30.61M (+25.4%)
-24.42M
est: -32.78M (+25.5%)
-28.13M
est: -31.76M (+11.4%)
-31.40M
est: -7.07M (-344.1%)
-26.87M
est: -23.89M (-12.5%)
-22.52M
est: -22.52M (+0.0%)
-21.24M
-25.60M – -16.88M
+5.7% YoY
-12.82M
-15.86M – -460.9K
+39.6% YoY
-2.34M
-2.85M – -1.84M
+81.7% YoY
-12.80M
-15.12M – -9.78M
-446.0% YoY
SGA
5.89M
est: 4.55M (+29.5%)
5.86M
est: 5.07M (+15.7%)
7.31M
est: 4.85M (+50.7%)
2.67M
est: 6.01M (-55.6%)
2.68M
est: 5.28M (-49.4%)
6.72M
est: 7.74M (-13.3%)
6.96M
est: 9.75M (-28.6%)
14.12M
est: 12.60M (+12.1%)
9.22M
est: 8.03M (+14.8%)
16.36M
12.99M – 18.49M
+103.6% YoY
32.41M
26.98M – 37.10M
+98.2% YoY
41.69M
41.64M – 41.74M
+28.6% YoY
50.13M
41.04M – 57.13M
+20.2% YoY
EPS
-0.54
est: -1.87 (+71.1%)
-2.00
est: -2.34 (+14.4%)
-0.69
est: -4.08 (+83.1%)
-0.66
est: -4.29 (+84.6%)
-0.62
est: -3.86 (+84.0%)
-0.60
est: -3.24 (+81.5%)
-0.73
est: -0.55 (-33.4%)
-0.36
est: -3.73 (+90.3%)
-1.70
est: -2.36 (+27.8%)
-1.48
-1.93 – -1.27
+37.0% YoY
-0.68
-1.19 – -0.03
+54.4% YoY
-0.18
-0.21 – -0.14
+73.2% YoY
-0.96
-1.14 – -0.74
-431.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-26 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-25 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-19 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-18 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-177.65M
OE per share TTM
-7.62
Owner's Yield
-95.87%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
812.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 2 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Avantis International Small Cap Equity ETF AVDS 0.01% 19.5K 0.30%
2 Dimensional - International Small Cap ETF DFIS 0.00% 3.9K 0.39%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-1.5K
Shares Outstanding
8.80M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Tom van Aken Chief Executive Officer & Member of Management Board 378.0K male
Carmen Portocarero General Counsel — female
Chie Cheung Yap Managing Director of Volta Technology — female
Gert-Jan Gruter Chief Technology Officer — male
Annelore Van Thiel Director of Human Resources — —
Marco Jansen Chief Commercial Officer — male
Rene Ploegsma Interim Chief Financial Officer — —
Steven Olivier Managing Director of Avantium R&D Solutions — male
Hero de Jager Interim Chief Operating Officer — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty